Fundz

Dechert Partners with Wharton School for Business Training Program

Oct 18, 2024

Contract Type

partnership

ParisBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalConsultingLegalBiopharma

Description

Dechert has partnered with the Wharton School of the University of Pennsylvania to offer a business program aimed at enhancing relationship-building and business education for mid-level associates. The program involved onsite classroom lectures and interactive exercises at Wharton's Philadelphia campus, enabling participants to deepen client relationships and anticipate risks associated with client businesses.

Company Information

Company

Abivax

Location

Rue De La Baume

Paris, Ile-de-France, France

About

Abivax is developing therapies that modulate the body’s natural immune system machinery. A clinical-stage company, Abivax leverages its immune enhancing and antiviral platforms to develop drug candidates to treat inflammatory diseases, viral diseases and liver cancer. Abivax is based on innovative research driven by the idea of modulating the body’s natural immune system mechanisms to treat diseases.

Related People

Michael
Likely contact at this company
••••••••@••••••••

See Michael's verified email →

Pierre
Senior decision-maker at this company
••••••••@••••••••

See Pierre's verified email →

Marc
Senior decision-maker at this company
••••••••@••••••••

See Marc's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Abivax 's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Abivax signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.